COLO-B.CO
Coloplast A/S
Copenhagen · DKK · Stock
DKK 482.30
+64.40 (+15.41%)
past month
Closed- Market cap
- DKK 108.7B
- P/E
- 39.34
- Yield
- 4.77%
- Volume
- 468.4K
- 52 weeks
- DKK 370 – DKK 631
About
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments.
Coloplast A/S (COLO-B.CO) is a healthcare company listed on Nasdaq Copenhagen, traded in DKK. Over the past year it moved between DKK 369.70 and DKK 631.40, and it pays a dividend twice a year.
- Healthcare
- Medical Instruments & Supplies
- Humlebæk, Denmark
- 17.2K employees
- Led by Anders Lonning-Skovgaard
Coming up
Earnings
Next report
Expected EPS DKK 5.73 · revenue DKK 7.41B
Financials
Revenue, last 12 months
DKK 28.44B+5.70%
Earnings
Beat the estimate
2 of 4 quarters
Q3 2025
-33.79%
Q4 2025
+4.18%
Q1 2026
-102.74%
Q2 2026
+8.26%
Earnings per share, last 12 months DKK 12.26
Analysts
21 analysts say
Hold
12-month targetDKK 461.62-4.29%
Dividends
Yield · per share, yearly
4.77%DKK 23.00
Ownership
- Institutions
- 29.44%
- Insiders
- 29.80%
Prices from Yahoo Finance, may be delayed
